Current Topics in Medicinal Chemistry

Volume 2, Number 3, 1 March 2002

Links for this Journal

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003
• Ingenta Connect ISSN
• Open URL

Book Reviews

Preface
pp. i-ii(1)
Authors: Neamati, N.; BarchiJr., J.J.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00001
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=i&epage=ii
• http://dx.doi.org/10.2174/1568026023394263

Reviews

New Paradigms in Drug Design and Discovery
pp. 211-227(17)
Authors: Neamati, N.; BarchiJr., J.J.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00002
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=211&epage=227
• http://dx.doi.org/10.2174/1568026023394227

Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery
pp. 229-246(18)
Authors: Shoemaker, R.H.; Scudiero, D.A.; Melillo, G.; Currens, M.J.; Monks, A.P.; Rabow, A.A.; Covell, D.G.; Sausville, E.A.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00003
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=229&epage=246
• http://dx.doi.org/10.2174/1568026023394317

Impact of Recombinant DNA Technology and Protein Engineering on Structure-Based Drug Design: Case Studies of HIV-1 and HCMV Proteases
pp. 247-269(23)
Author: Kan, C-C.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00004
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=247&epage=269
• http://dx.doi.org/10.2174/1568026023394218

Photoaffinity Labeling in Drug Discovery and Developments: Chemical Gateway for Entering Proteomic Frontier
pp. 271-288(18)
Authors: Hatanaka, Y.; Sadakane, Y.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00005
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=271&epage=288
• http://dx.doi.org/10.2174/1568026023394182

RNA and RNA-Protein Complexes as Targets for Therapeutic Intervention
pp. 289-302(14)
Authors: Dejong, E.S.; Luy, B.; Marino, J.P.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00006
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=289&epage=302
• http://dx.doi.org/10.2174/1568026023394245

Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents
pp. 303-323(21)
Authors: Ohkanda, J.; Knowles, D.B.; Blaskovich, M.A.; Sebti, S.M.; Hamilton, A.D.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00007
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=303&epage=323
• http://dx.doi.org/10.2174/1568026023394281

Cyclization Strategies in Peptide Derived Drug Design
pp. 325-341(17)
Authors: Li, P.; Roller, P.P.

Links for this article

• http://www.ingentaconnect.com/content/ben/ctmc/2002/00000002/00000003/art00008
• http://openurl.ingenta.com/content?genre=article&issn=1568-0266&volume=2&issue=3&spage=325&epage=341
• http://dx.doi.org/10.2174/1568026023394209